Healthcare ❯ Pharmaceuticals ❯ Drug Development

Weight Loss Drugs

Mounjaro Zepbound Semaglutide GLP-1 Drugs GLP-1 Medications Clinical Trials MariTide Market Competition Diabetes Medications Incretin and Non-Incretin Peptides Eli Lilly Eli Lilly and Company GLP-1 Products Eli Lilly Products

3 ARTICLES

4mo ago

Oral GLP‑1s Reshape Obesity Market as Approvals, Policy Talks and M&A Accelerate Growth

The move from injectables to daily pills is broadening patient access and forcing drugmakers and suppliers to race for approvals, capacity and commercial deals.

8 ARTICLES

6mo ago

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

9 ARTICLES

8mo ago

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

3 ARTICLES

10mo ago

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

3 ARTICLES

last yr.

Texas Sues Eli Lilly Over Alleged Physician Kickbacks for Zepbound and Mounjaro

7 ARTICLES

last yr.

Eli Lilly Raises 2025 Outlook as Tirzepatide Sales Soar, Orforglipron Misses Marks